News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Next Science.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Immutep hooks leading research firm CHDR to conduct Phase 1 drug study
News
Closing Bell: ASX selloff softens… then pummels again last minute; Rinehart ups stake in Lynas
Health & Biotech
ASX Health Stocks: Firebrick skyrockets 80pc on Nasodine’s US launch
News
Market Highlights: Rates sensitive stocks on watch today after Powell’s remarks; IMF sees good times ahead
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX gains as lithium, iron ore miners dazzle; copper and gold stocks extend rally
Health & Biotech
ASX Health Stocks: Patrys and Next Science jump after presenting data on studies
Health & Biotech
ASX Health Stocks: Next Science jumps almost 10pc after XPERIENCE study published in science journal
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps and IPO Weekly Wrap: A Benchmark bonanza, but harder to pick than a broken nose
Health & Biotech
REPORT: ASX wound care is rapidly becoming an ‘exciting subsector’
News
In Case You Missed It: A coal takeover attempt and gold plays round out the day
Experts
Dr Boreham’s Crucible: With a US focus, can Next Science’s new leaders stem the bleeding?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: An unlikely bunch of small cap heroes bring it home for the ASX on Tuesday
Health & Biotech
ASX Health Stocks: Cyclopharm confident after US FDA inspection; Anteris a step closer to FDA approval
Health & Biotech